Cargando…
Fasting apolipoprotein B48 is associated with large artery atherosclerotic stroke: a case-control study
Fasting Apolipoprotein B48 (ApoB48) is reported to be a well surrogate marker for postprandial lipidemia and have been repeatedly associated with cardiovascular disease. However, whether ApoB48 is also a risk factor for ischemic stroke have not been reported. In this study, our object is to explore...
Autores principales: | Tian, Jing, Chen, Hong, Liu, Ping, Wang, Chun, Chen, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403240/ https://www.ncbi.nlm.nih.gov/pubmed/30842592 http://dx.doi.org/10.1038/s41598-019-40385-0 |
Ejemplares similares
-
Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017) -
Apolipoprotein C3 and apolipoprotein B colocalize in proximity to macrophages in atherosclerotic lesions in diabetes
por: Kanter, Jenny E., et al.
Publicado: (2020) -
Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke
por: Pan, Xudong, et al.
Publicado: (2015) -
Apolipoprotein B/AI ratio as an independent risk factor for intracranial atherosclerotic stenosis
por: Sun, Yan, et al.
Publicado: (2019) -
Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients with type 2 diabetes: A randomized controlled trial
por: Onoue, Takeshi, et al.
Publicado: (2020)